{"filing":{"accession_number":"0001773751-26-000161","cik":"0001773751","ticker":"HIMS","company_name":"Hims \u0026 Hers Health, Inc.","form":"8-K","filing_date":"2026-08-10","report_date":"2026-08-10","primary_document":"hims-20260810.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1773751/000177375126000161/hims-20260810.htm"},"events":[{"id":26561,"run_id":24144,"accession_number":"0001773751-26-000161","anchor_item_number":"2.02","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"summary":"This is a clear earnings release disclosing Q2 2026 financial results for Hims \u0026 Hers Health, Inc. The Item 2.02 filing announces quarterly revenue of $753.2 million (up 38% YoY), subscriber growth to 2.9 million (up 19% YoY), and raised full-year 2026 guidance to $3.1–$3.3 billion revenue and $275–$325 million Adjusted EBITDA. The press release is furnished as Exhibit 99.1 and constitutes a standard quarterly earnings announcement with detailed financial metrics, business highlights, and forward guidance.","company_name":"Hims \u0026 Hers Health, Inc.","ticker":"HIMS","filing_date":"2026-08-10","form":"8-K","submitted_at":null,"items":[{"id":27727,"accession_number":"0001773751-26-000161","item_number":"2.02","item_title":null,"event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"This is a clear earnings release disclosing Q2 2026 financial results for Hims \u0026 Hers Health, Inc. The Item 2.02 filing announces quarterly revenue of $753.2 million (up 38% YoY), subscriber growth to 2.9 million (up 19% YoY), and raised full-year 2026 guidance to $3.1–$3.3 billion revenue and $275–$325 million Adjusted EBITDA. The press release is furnished as Exhibit 99.1 and constitutes a standard quarterly earnings announcement with detailed financial metrics, business highlights, and forward guidance.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-10T20:15:12.422836+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":27727,"accession_number":"0001773751-26-000161","item_number":"2.02","item_title":null,"event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"This is a clear earnings release disclosing Q2 2026 financial results for Hims \u0026 Hers Health, Inc. The Item 2.02 filing announces quarterly revenue of $753.2 million (up 38% YoY), subscriber growth to 2.9 million (up 19% YoY), and raised full-year 2026 guidance to $3.1–$3.3 billion revenue and $275–$325 million Adjusted EBITDA. The press release is furnished as Exhibit 99.1 and constitutes a standard quarterly earnings announcement with detailed financial metrics, business highlights, and forward guidance.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-10T20:15:12.422836+00:00","company_name":"Hims \u0026 Hers Health, Inc.","ticker":"HIMS","filing_date":"2026-08-10"}]}